問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
黃國倫
下載
2017-11-01 - 2021-12-08
Condition/Disease
Acute primary cerebral hemorrhage
Test Drug
Three-dose combination(telmisartan, amlodipine, indapamide)
Participate Sites4Sites
Recruiting3Sites
Study ended1Sites
Division of Neurology
2019-01-01 - 2020-12-31
Alzheimer's disease
18F-PMPBB3
Participate Sites2Sites
Recruiting2Sites
2019-08-01 - 2021-07-31
investigate the deposition patterns of tau protein with 18F-PM-PBB3 and amyloid protein with 18F-flobetapir in patients with amnestic mild cognitive impairment due to AD
18F-AV-45 for Injection, and 18F-PM-PBB3 for Injection
Participate Sites1Sites
Recruiting1Sites
2016-07-01 - 2023-05-09
2017-08-01 - 2023-12-01
2020-05-18 - 2023-12-31
Alzheimer's Disease
Aducanumab
Participate Sites5Sites
Not yet recruiting3Sites
2018-11-01 - 2023-10-31
Brain Edema, Acute Stroke
BIIB093
Recruiting4Sites
全部
